|Bid||2.94 x 9600|
|Ask||3.12 x 300|
|Day's Range||2.95 - 3.15|
|52 Week Range||0.98 - 3.43|
|PE Ratio (TTM)||-5.18|
|Earnings Date||Nov 6, 2017 - Nov 10, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||3.88|
BioScrip's (BIOS) progressive CORE plan should enhance its financial position. However, the company's 2017 outlook loses steam based on an anticipated adverse impact of Cures Act legislation.
Q1 2017 BioScrip Inc Earnings Call
BioScrip, Inc. (BIOS) moved big last session, as its shares jumped almost 7% on the day.